repaglinide has been researched along with cysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| David, LL; Innes, LM; Kandasamy, B; Martin, GM; Shyng, SL; Sung, MW; Yang, Z; Yoshioka, C | 1 |
1 review(s) available for repaglinide and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for repaglinide and cysteine
| Article | Year |
|---|---|
Mechanism of pharmacochaperoning in a mammalian K
Topics: Animals; Binding Sites; Carbamates; Cell Line; Cricetinae; Cryoelectron Microscopy; Cysteine; Glyburide; Humans; KATP Channels; Mammals; Models, Molecular; Mutation; Pharmaceutical Preparations; Piperidines; Potassium Channels, Inwardly Rectifying; Protein Binding; Rats | 2019 |